<strong class="sub-title"> Background and aim: </strong> The Toll-like receptor 4 (TLR4)/nuclear factor kappa B (<em>N</em>F-κB) signaling pathway is essential in the pathogenesis of hepatic ischemia/ reperfusion (HIR) injury. Pyroptosis is a proinflammatory programmed cell death that is related to several diseases. Thus, the purpose of this study was to examine whether pretreatment with octreotide (somatostatin analogue, OCT) at different doses or OCT at 7<em>5</em> μg/kg combined with melatonin (<em>N</em>-<em>acetyl</em>-<em>5</em>-<em>methoxytryptamine</em>, MLT) could produce hepatic protection against HIR injury.
<strong class="sub-title"> Methods: </strong> Rats were randomized into sham, HIR, OCT (<em>5</em>0, 7<em>5</em>, and 100 μg/kg, respectively), MLT, and MLT + OCT7<em>5</em> groups. Ischemia was induced for 30 min followed by 24 h reperfusion.
<strong class="sub-title"> Results: </strong> OCT pretreatment at doses (<em>5</em>0 or 7<em>5</em> μg/kg), MLT alone, and MLT + OCT7<em>5</em> significantly ameliorated the biochemical with histopathological changes, oxidative stress, inflammation, apoptosis, then augmented anti-oxidant and anti-apoptotic markers with downregulation of HMGB1, TLR4, MyD88, TRAF-6, p-IκBα (S32), p-<em>N</em>F-κBp6<em>5</em> (S<em>5</em>36), <em>N</em>LRP3, ASC, caspase-1(p20), and GSDMD-<em>N</em> expressions compared with HIR group. Lastly, Octreotide showed for the first time a hepatoprotective effect against HIR injury via inhibiting TLR4-<em>N</em>LRP3-mediated pyroptosis in rats. As well, OCT7<em>5</em> was more effective than MLT and was not enhanced after the addition of MLT through downregulation of TLR4/MyD88/<em>N</em>F-κB/<em>N</em>LRP3 inflammasome pathway.
Keywords: Hepatic ischemia/reperfusion injury; Melatonin; NLRP3; Octreotide; Pyroptosis; TLR4.